They may have a full year of NHS under their belts, but I don't think many physicians even know about ActiPatch. They will go after post surgical use in Germany and the other B Braun markets in the future. Until they have money to advertise and pay sales reps the other areas are mostly out of reach. Upfront money from Dr Scholls and some info on the cost benefit (since NHS) of ActiPatch would certainly help.
News 
Market Data 
Discover 
